Asuragen to Develop BCR-ABL1 RT-qPCR Testing Calibrators, Software for Novartis

Asuragen will develop Armored RNA Quant BCR-ABL1 RNA International Scale calibrators and laboratory software reporting tools to help laboratories standardize testing when treating Philadelphia chromosome-positive chronic myelogenous leukemia patients with Novartis' Gleevec.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.